Europe’s healthcare biotech:

How to create a healthier, wealthier Europe

Healthcare biotech is a diverse sector, with thousands of companies in Europe ranging from large multinational enterprises – with global annual sales exceeding €10 billion and annual research and development (R&D) expenditures of €1 – €4 billion – to much smaller enterprises with fewer than ten employees and only grant-based income. It also includes hundreds of thousands of talented researchers, doctors and healthcare workers – all striving to push the frontiers of medical know-how. The event will bring together EU and national policy and decision makers as well as other stakeholders to discuss Healthcare Biotech Value Chain.


9 October 2014